Procter & Gamble Co

Procter & Gamble (PG) posted stronger-than-expected third-quarter results on Tuesday, April 23.

Net sales in North America fell 5.0% in 1Q17, reflecting a strong decline in volumes coupled with lower pricing.

Lower pricing adversely impacted Procter & Gamble’s (PG) sales across product segments amid increased competitive activity.

Colgate-Palmolive (CL) has a market capitalization of $60.9 billion. CL rose by 0.37% to close at $68.23 per share as of March 10, 2016.

JPMorgan’s latest 2Q14 results beat estimates. Meanwhile, net income was down to $6 billion from $6.5 billion in 2Q13. The earnings per share (or EPS) was $1.46, compared to $1.60 in 2Q13.

The Board’s Consumer Confidence Index rose to 92.6 in December—compared to 91 in November. For November, the index was revised from an initially reported value of 88.7.

By the end of August, the S&P Consumer Staples had outperformed the S&P Consumer Discretionary and SPY with respective returns of 0.89%, -0.18%, and 0.50%.

Pershing Square disclosed a new position in Platform Specialty Products (PAH) that accounts for 7.58% of Pershing Square’s 1Q14 portfolio.

International brands such as Estée Lauder (EL), L’Oréal (LRLCY), Procter & Gamble (PG), Shiseido (SSDOY), and Nivea (BDRFF) dominate the cosmetics market in China.

The Procter & Gamble Company, or P&G, is the largest household and personal products company in the world. It was established in 1837 by William Procter and James Gamble.

Last week, Pershing Square exited its entire stake in General Growth Properties.

Despite currency headwinds, Estée Lauder’s (EL) worldwide gross profit margin increased to 80.3% in fiscal 2014 from 80.1% in fiscal 2013.

Procter & Gamble (PG) has a market cap of $224.1 billion. PG rose by 0.35% to close at $82.84 per share on March 3, 2016.

Coty Inc.’s capital expenditure decreased 15.2% to $0.17 billion in fiscal 2015, compared to $0.20 billion in fiscal 2014.

Pershing Square increased its position in Air Products and Chemicals, Inc. from 21.31% in 3Q 2013 to 27.91% in 4Q 2013.

Estée Lauder’s sales growth was ranked third-highest globally among leading cosmetic companies between the years 2012 to 2015, with net revenue of $11 billion in fiscal year 2014.

Procter & Gamble (PG) is set to release its fiscal 3Q16 earnings before the Markets open on April 26, 2016. In fiscal 2Q16, P&G missed revenue estimates for the fifth consecutive quarter.

Business intelligence firm eMarketer estimates that CPG brands spent more than $7.0 billion on digital advertising in 2017, compared with $6.0 billion in 2016.

For distribution in the United States, Clorox (CLX) sells or markets its products primarily through mass retail outlets, e-commerce channels, wholesale distributors, and medical supply distributors.

P&G plans to focus on superior brands in the 10 product categories in its portfolio. It expects one-third of them to surpass $1 billion in annual sales.

Estée Lauder aims to expand its geographical market share in China, the Middle East, Eastern Europe, Brazil, and South Africa by focusing on consumers who purchase in travel retail channels.

Of all the Fortune 500 companies, only 5% have women CEOs. We rounded up five of the biggest names investors should know. Here’s why. 

The 1Q16 margins of consumer packaged goods (or CPG) companies sent strong signals. These companies have been investing heavily in innovative products and other growth initiatives.

Colgate-Palmolive (CL) posted net sales of $3.8 billion, a decline of about 2% on a YoY (year-over-year) basis, as unfavorable currency rates hurt the top line by 5%.

Costco’s suppliers include companies like PepsiCo (PEP), Procter & Gamble (PG), and the Kraft Heinz Company (KHC). No single supplier accounts for over 5% of revenue.

On February 29, 2016, Procter & Gamble (PG) announced the completion of the transfer of its Duracell business to Berkshire Hathaway (BRK-B).

On September 28, the S&P 500 outperformed the S&P Consumer Discretionary and the S&P Consumer Staples, which saw returns of 0.53%, 0.30%, and 0.11%.

Colgate’s worldwide gross profit margin fell to 58.5% in 2014 from 58.6% in 2013.

The COVID-19 pandemic boosted Clorox’s sales. People started paying more attention to cleaning and sanitizing.

The defensive nature of Procter & Gamble stock and its strong dividends make it a good buy in a challenging market environment.

Clorox stock rose 4.1% on March 16, even though the US stock market crashed amid the coronavirus pandemic. JPMorgan Chase upgraded its rating.

Although Church & Dwight stock is trading in the green, it has lagged its peers and the broader markets. The stock didn’t repeat its 2018 performance.

Procter & Gamble stock has generated a significant amount of wealth for investors this year. The company boosted shareholders’ returns.

Colgate-Palmolive released its third-quarter earnings results today. The company’s performance was mixed, irking investors.

Procter & Gamble stock trades at 24.7x its fiscal 2020 estimated core EPS of $4.85. The stock trades at 23.2x its fiscal 2021 estimated core EPS of $5.17.

Church & Dwight (CHD) stock has risen 9.5% on a YTD (year-to-date) basis as of September 13. However, the stock lags its peers by a wide margin.

Procter & Gamble stock benefits from its strong organic sales. On average, the company’s organic sales have increased by 5% in the last four quarters.

Clorox stock (CLX) is down about 8% since the company posted its third quarter of fiscal 2019 earnings on May 1.

Clorox (CLX) posted net sales of $1.55 billion, which fell short of Wall Street’s estimate of $1.57 billion.

The Consumer Staples Select Sector SPDR ETF (XLP) rose 10.5% in the first quarter of 2019.

Clorox (CLX) posted net sales of $1.47 billion during the second quarter.

Procter & Gamble (PG) stock trades at 20.8x its estimated fiscal 2019 EPS of $4.41, which doesn’t look attractive.

I bet you may have heard a lot about investing defensively while the market faded.

The consumer non-cyclical segment recorded a dividend yield of 3%.

The consumer staples sector is an important sector in the S&P 500 Index (SPY).

Kimberly-Clark’s (KMB) Personal Care segment returned to growth in 4Q17. The segment’s top line increased 1.2% to $2.3 billion.

As of November 24, 2017, Colgate-Palmolive (CL) stock was trading at a forward PE multiple of 24.0x, which is higher than its peers.

Wall Street analysts estimate Merck’s (MRK) top line will increase marginally by 0.1% to ~$10,546 million in 3Q17.

The majority of analysts providing recommendations on Colgate-Palmolive (CL) stock maintain a neutral outlook.

Procter & Gamble’s (PG) PE ratio of 25.1x compares to a sector average of 23.3x. The dividend yield of 3.0% compares to a sector average of 3.8%.